Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TERIFLUNOMIDE, with a corresponding US DMF Number 28991.
Remarkably, this DMF maintains an Active status since its submission on March 20, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 19, 2015, and payment made on March 20, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II